SERTAD3
SERTA domain-containing protein 3
Also known as: RBT1, SRTD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJW9
- Gene
- SERTAD3
- Ensembl
- ENSG00000167565
- Chromosome
- 19
- Canonical length
- 196 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
The protein encoded by this gene was identified in a yeast two-hybrid assay employing the second subunit of human replication protein A as bait. It is localized to the nucleus and its expression is significantly higher in cancer cell lines compared to normal cell lines. This protein has also been shown to be a strong transcriptional co-activator. Alternative splicing has been observed at this locus and two variants, both encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
196 residues, UniProt reviewed canonical sequence.
>Q9UJW9|SERTAD3
1 MVGGLKRKHS DLEEEEERWE WSPAGLQSYQ QALLRISLDK VQRSLGPRAP SLRRHVLIHN
61 TLQQLQAALR LAPAPALPPE PLFLGEEDFS LSATIGSILR ELDTSMDGTE PPQNPVTPLG
121 LQNEVPPQPD PVFLEALSSR YLGDSGLDDF FLDIDTSAVE KEPARAPPEP PHNLFCAPGS
181 WEWNELDHIM EIILGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SERTAD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 40 nTPM
- adipose tissue: 36 nTPM
- tongue: 35 nTPM
- colon: 35 nTPM
- heart muscle: 33 nTPM
- fallopian tube: 31 nTPM
Single-cell type
- syncytiotrophoblasts: 223 nCPM
- extravillous trophoblasts: 140 nCPM
- esophageal apical cells: 131 nCPM
- migrating cytotrophoblasts: 123 nCPM
- breast hormone-responsive cells: 116 nCPM
- breast secretory cells: 114 nCPM
Immune cell
- neutrophil: 81 nTPM
- plasmacytoid DC: 70 nTPM
- eosinophil: 66 nTPM
- myeloid DC: 65 nTPM
- intermediate monocyte: 59 nTPM
- classical monocyte: 59 nTPM
Brain region
- medulla oblongata: 18 nTPM
- white matter: 17 nTPM
- thalamus: 14 nTPM
- midbrain: 14 nTPM
- spinal cord: 14 nTPM
- basal ganglia: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell growth
- positive regulation of DNA-templated transcription
- regulation of DNA-templated transcription
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SERTA domain
- SERTA motif
- SERTA domain-containing protein 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SERTAD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SERTAD3 as an antibody target. Whether an autoantibody or antibody against SERTAD3 could matter depends on whether native SERTAD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SERTAD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SERTAD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...